Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05140460 · ClinicalTrials.gov registry record · NA
Cultural Pride Reinforcement for Early School Readiness
A NA study, sponsored by Children's Hospital Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT05140460 is a NA study that has completed, run by Children's Hospital Los Angeles. The registered enrollment target is 106 participants.
The verdict
NCT05140460, a NA study, has completed, sponsored by Children's Hospital Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
Minority children disproportionately experience racial bias, which is linked to school failure, toxic stress, and health disparities. In contrast, a type of racial socialization called cultural pride reinforcement has been associated with positive academic, behavioral, and mental health outcomes. A clinic-based intervention to boost cultural pride may help parents foster resilience in their young children against the negative effects of racial bias. The investigators evaluated the extent to which a standard clinic-based early literacy program (Reach Out and Read (ROR)) and a similar program enhanced with cultural pride content (Cultural Pride Reinforcement for Early School Readiness (CPR4ESR)) are associated with improved cultural pride reinforcement practices, child development, family-provider communication, and health care utilization. Given the high representation of young children of color in the sample, the investigators hypothesized better outcomes among those who received the culturally tailored CPR4ESR program compared to those who received the standard ROR program.
Interventions
- BEHAVIORAL Cultural Pride Reinforcement for Early School Readiness (CPR4ESR)
- BEHAVIORAL Reach Out and Read (ROR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2018-08-06 |
| Est. Completion | 2019-11-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05140460
The ClinicalTrials.gov registry entry for NCT05140460 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cultural Pride Reinforcement for Early School Readiness (CPR4ESR) is the first listed.
NCT05140460 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05140460 about?
NCT05140460 is a clinical study titled "Cultural Pride Reinforcement for Early School Readiness". Minority children disproportionately experience racial bias, which is linked to school failure, toxic stress, and health disparities. In contrast, a type of racial socialization called cultural pride reinforcement has been associated with positive academic, behavioral, and mental health outcomes. A ...
What is the current status of trial NCT05140460?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2018-08-06. Estimated completion is 2019-11-25.
What interventions are being tested in trial NCT05140460?
The interventions under investigation include: Cultural Pride Reinforcement for Early School Readiness (CPR4ESR) (BEHAVIORAL), Reach Out and Read (ROR) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05140460?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.